Connect with us

Published

on

Former Theranos CEO Elizabeth Holmes leaves after a hearing at a federal court in San Jose, California, July 17, 2019.
Stephen Lam | Reuters

Nearly a decade ago, Elizabeth Holmes was proclaimed the golden girl of Silicon Valley, and briefly crowned America’s youngest female self-made billionaire.

This week, she’ll walk into a San Jose federal courthouse with a very different image: a defendant charged accused of fraud. 

Federal prosecutors in the Northern District of California have accused Holmes and Ramesh “Sunny” Balwani, former Theranos president and for a time her romantic partner, of defrauding investors and patients. They each face two counts of conspiracy to commit wire fraud and 10 counts of wire fraud. Holmes and Balwani, who will be tried separately, pleaded not guilty.

Jury selection in Holmes’ trial will begin Tuesday and is expected to take at least two days, a process that typically takes less than a day in lower-profile cases. Opening statements are scheduled for Sept. 8 and the trial is expected to last 13 weeks.

If convicted, Holmes could face 20 years in prison. Prosecutors say Holmes not only swindled investors of hundreds of millions of dollars, but she also put thousands of lives at risk.

The rise and fall of Theranos

Holmes’ saga began when she had a vision of running hundreds of laboratory tests with just a finger prick of blood. She dropped out of Stanford at age 19 to start Theranos. The idea was to make blood tests cheaper, convenient and accessible to consumers.

The company struck partnerships with Walgreens and the grocery chain Safeway. Her board of directors included luminaries such as former Secretaries of State Henry Kissinger and the late George Shultz and former Secretary of Defense James Mattis.

But Holmes’ vision turned upside down in 2015 after Wall Street Journal reporter John Carreyrou published a series of damning reports exposing the shortcomings and inaccuracies of Theranos’ technology.

Patients were given inaccurate test results relating to conditions such as HIV, cancer and miscarriages.

“She commercialized a medical product that she knew did not work, her machine only did a handful of tests that did not do them well at all,” Carreyrou said in an interview with CNBC last week.

In 2018, Holmes and Balwani were charged with “massive fraud” by the Securities and Exchange Commission. That led to Theranos being dissolved and Holmes settling with the SEC. She agreed to pay $500,000 without admitting or denying the charges. Balwani intends to fight the SEC charges.

The investors

Holmes once had some of the most powerful and wealthiest venture capitalists in America behind her healthcare start-up Theranos.

Investors such as media mogul Rupert Murdoch, former Education Secretary Betsy DeVos, the Walton family of Walmart fame, the Cox family, Patriots owner Robert Kraft and Mexican investor Carlos Slim became so enchanted with her they poured millions into Theranos.

Some of those investors are expected to testify in Holmes’ trial. All of the major investors, who doled out $700 million over the course of a decade, did not respond to CNBC’s request for a comment. Prosecutors allege the investors were swayed by exaggerations and misrepresentations of the blood-testing technology.

“When a deal turns into this, you don’t want to be on that list of investors anymore,” said Kevin O’Leary, chairman of O’Shares ETFs and a judge on CNBC’s “Money Court.”

O’Leary, who said about 20% of his investments have failed, didn’t mince words when asked about the fallout from Theranos investors.

“You can understand how embarrassing it is to get a zero like that,” O’Leary said. “Clearly means you didn’t do your due diligence which all investors know is a mistake. When there’s a really hot deal, what suffers immediately is the diligence process. You’re just questioning if you can get into the deal.”

According to the indictment, prosecutors say there were six wire transfers from unnamed investors that they allege were the result of fraudulent claims about what they were getting in return.

“It’s going to be highly scrutinized and the investors will be dragged back into the press again and shamed for it,” O’Leary said. “I can guarantee you this, it will change nothing. When this is over whatever happens, it will happen again. I guarantee nothing changes in regards to investment in Silicon Valley.”

A Silicon Valley tale

Instead of being an example of Silicon Valley’s best, Theranos turned into a black eye for start-ups.

One of Holmes’ defense strategies may be to blame the so-called “fake it ’til you make it” motto of Silicon Valley. Earlier this year, the judge ruled her defense team can lean on the hype and exaggeration of start-up founders to explain Holmes’ own actions. 

“It’s going to be a wake-up call for venture capitalists and young entrepreneurs in Silicon Valley,” Carreyrou said. “If you go too far, if you push the envelope and hype and exaggerate to the point of lying, it becomes securities fraud.”

However, if she’s found not guilty, some say it could encourage risk taking.

“It’s going to a take guilty verdict to course correct and even a guilty verdict in this case might not be enough,” Carreyrou said.

Mental health defense

Explosive new court documents unsealed just days before jury selection shed light on how Holmes’ lawyers might mount a mental health defense. In the filings, Holmes claims she was the victim of “a decade-long” abuse by Balwani, whom she met when she was 18.

The documents reveal she plans to claim he psychologically, emotionally and sexually abused her. According to one filing, Holmes accused Balwani of throwing sharp objects at her, controlling what she ate, when she slept, how she dressed and monitoring her calls and text messages. Balwani denied the claims.

The court filings also revealed Holmes plans to take the stand in her own defense, a move many legal experts say is a risky one.

“It’s an uphill battle: Balwani may have exercised influence on her, due to his age or prior successes,” said Danny Cevallos, an NBC News legal analyst. “But will she convince a jury that his influence excused her own conduct?”

Today, with her trial repeatedly delayed she’s now the mother of a newborn. Holmes, who once was a ubiquitous presence in the media, stays silent and ignores reporters’ questions every time she enters and exits the courthouse.

That will all change if she does indeed take the stand to finally tell her side of the story.

Continue Reading

Technology

Trump renominates Musk ally Jared Isaacman to run NASA months after withdrawal

Published

on

By

Trump renominates Musk ally Jared Isaacman to run NASA months after withdrawal

Jared Isaacman, U.S. President Donald Trump’s nominee to be administrator of the National Aeronautics and Space Administration (NASA) testifies during a Senate Commerce, Science, and Transportation confirmation hearing on Capitol Hill in Washington, D.C., U.S., April 9, 2025.

Ken Cedeno | Reuters

President Donald Trump has renominated Jared Isaacman to run NASA after pulling his prior nomination months ago due to what the president called a “thorough review of prior associations.”

“Jared’s passion for Space, astronaut experience, and dedication to pushing the boundaries of exploration, unlocking the mysteries of the universe, and advancing the new Space economy, make him ideally suited to lead NASA into a bold new Era,” Trump wrote in a post on Truth Social on Tuesday.

Isaacman, who is friends with Tesla CEO Elon Musk, was originally picked to lead NASA in December, before Trump had even taken office. Isaacman is a billionaire who founded payments company Shift4 and has led two private spaceflights.

But Trump pulled the nomination in late May after a spat between the president and Musk, who had been leading a White House effort to slash the size of the federal government. Trump said at the time that he was withdrawing the pick because of Isaacman’s past associations, though he didn’t specify what those were. Some reports have suggested that it was a reference to Isaacman’s prior donations to Democrats.

Days after the withdrawal, Isaacman told Shift4 investors in a letter that his “brief stint in politics was a thrilling experience.” He also said that he was resigning as CEO of Shift4, which he founded in 1999 at age 16, and would assume the role of executive chairman. He had been planning to leave the company if his nomination was confirmed by the Senate. But it never got that far.

Transportation Secretary Sean Duffy has been running NASA as interim head since July.

Isaacman still must go through the Senate confirmation process. The federal government has been shut down since the beginning of October, but the Senate is still able to confirm presidential nominees.

WATCH: Trump renominates Jared Isaacman to run NASA

Pres. Trump re-nominates fmr. Shift4 Payments CEO Jared Isaacman to be head of NASA

Continue Reading

Technology

Super Micro stock drops on slumping sales, weak earnings

Published

on

By

Super Micro stock drops on slumping sales, weak earnings

Charles Liang, CEO of Super Micro Computer Inc., during the Computex conference in Taipei, Taiwan, on June 5, 2024.

Annabelle Chih | Bloomberg | Getty Images

Super Micro Computer shares plunged as much as 10% in extended trading on Tuesday after the server maker issued weaker-than-expected results for the fiscal first quarter.

Here’s how the company did in comparison with analyst estimates compiled by LSEG:

  • Earnings per share: 35 cents adjusted vs. 40 cents expected
  • Revenue: $5.02 billion vs. $6 billion expected

Revenue fell 15% from $5.94 billion a year ago, Super Micro said in a statement. The report comes about two weeks after Super Micro issued preliminary earnings and said it expected revenue of $5 billion for the quarter, down from prior guidance of $6 billion to $7 billion.

Net income fell by more than half to $168.3 million, or 26 cents a share, from $424.3 million, or 67 cents a share, a year earlier.

In its partial report last month, Super Micro said “design win upgrades” pushed some expected first-quarter revenue to the second quarter. The company said it now expects sales of $10 billion to $11 billion in the current quarter, above the $7.83 billion average estimate, according to LSEG.

Super Micro has been a big beneficiary of the artificial intelligence boom, as its servers come packed with graphics processing units from Nvidia. But after growth soared from late 2023 through last year, the business has flatlined, with some analysts saying that Dell has taken market share.

Prior to Tuesday’s report, the stock was up 55% for the year.

WATCH: Going short on AI is a bad idea

Going short on AI is an absolute bad idea, says KKM Financial's Jeff Kilburg

Continue Reading

Technology

AMD reports better-than-expected results but margin guidance only meets estimates

Published

on

By

AMD reports better-than-expected results but margin guidance only meets estimates

AMD CEO Lisa Su speaks at a Senate Commerce, Science, and Transportation Committee hearing in Washington on May 8, 2025. The leaders of some of the biggest technology and artificial intelligence companies will go to Congress on Thursday with a wish list of sorts that at its top has doing away with regulation they say inhibits their firms’ growth and by default, sends business to China.

Nathan Howard | Bloomberg | Getty Images

Advanced Micro Devices reported fiscal third-quarter results that exceeded Wall Street expectations, but gave margin guidance was inline with estimates. The stock slipped in extended trading.

Here’s how the company did in comparison with LSEG consensus:

  • Earnings per share: $1.20 adjusted vs. $1.16 expected
  • Revenue: $9.25 billion vs. $8.74 billion expected

Revenue increased 36% from a year earlier in the fiscal third quarter, which ended on Sept. 27, according to a statement.

Net income climbed to $1.24 billion, or 75 cents per share, from $771 million, or 47 cents per share, a year earlier.

For the fourth quarter, AMD expects about $9.6 billion in revenue, implying 25% growth. That’s above LSEG’s $9.15 billion consensus. AMD sees an adjusted gross margin of 54.5% for the quarter, meeting StreetAccount’s consensus of 54.5%.

AMD, which is trying to keep pace with Nvidia in the market for artificial intelligence processors, said the guidance does not include revenue from shipments of its Instinct MI308 chips to China. Executives said the same thing last quarter.

As of Tuesday’s close, AMD shares were up 107% so far this year, while the Nasdaq is up 21%.

AMD reached a deal with OpenAI last month that could see the AI startup company take a 10% stake in the chipmaker. OpenAI will deploy 6 gigawatts of AMD’s Instinct graphics processing units over multiple years and across multiple generations of hardware, the companies said, beginning with an initial 1-gigawatt rollout of chips in the second half of next year.

For years OpenAI and other companies relied on graphics chips from Nvidia for running large-scale AI models.

Also in October, Oracle announced plans to deploy 50,000 AMD Instinct MI450 AI chips in its cloud starting next year.

AMD’s data center business, which includes standard central processing units and GPUs for AI, generated $4.34 billion in fiscal third-quarter revenue, up 22%. Analysts polled by StreetAccount were looking for $4.13 billion.

Client revenue reached $2.75 billion, which was up 46% and more than StreetAccount’s $2.61 billion consensus. Revenue from gaming totaled $1.30 billion, up 181%. StreetAccount’s consensus was $1.05 billion.

Amazon, a key cloud customer for AMD, disclosed in a Tuesday filing that it had sold all 822,234 of its AMD shares as of Sept. 30. Amazon built the position sometime in the first quarter.

Executives will discuss the results with analysts on a conference call starting at 5 p.m. ET.

This is developing news. Please check back for updates.

WATCH: AMD CEO on new $1 billion AI supercomputer partnership with the Department of Energy

AMD CEO on new $1 billion AI supercomputer partnership with the Department of Energy

Continue Reading

Trending